Key Insights

Highlights

Treatment Research

7 treatments under study, led by Smoliv

Related Conditions

Often studied with 17 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04846010Phase 1Unknown

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Showing all 1 trials

Research Network

Common Treatments

  • Smoliv1
  • Purwet1
  • Purapo1
  • Furfat1
  • Purphl1

Active Sponsors

  • All Natural Medicine Clinic Llc1

Related Conditions

  • Depression Anxiety1
  • Depression Bipolar1
  • Sequelae Of Infection1
  • Postinfectious Arthritis1
  • Postinfectious Polyneuritis1

Activity Timeline